Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
NCT ID: NCT00736346
Last Updated: 2008-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
204 participants
INTERVENTIONAL
2005-10-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Brief cognitive-behavioral treatment for Panic Disorder
One two-hour session of cognitive-behavior therapy for panic disorder
2
Cognitive-Behavior Therapy for Panic Disorder
Seven one-hour sessions of cognitive-behavior therapy for panic disorder
3
paroxetine
40 mg die, for 6 months
4
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief cognitive-behavioral treatment for Panic Disorder
One two-hour session of cognitive-behavior therapy for panic disorder
Cognitive-Behavior Therapy for Panic Disorder
Seven one-hour sessions of cognitive-behavior therapy for panic disorder
paroxetine
40 mg die, for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mastered oral and written French
* Consulted an emergency department for chest pain with very low risk of coronary disease (normal ECG and blood tests)
* Met criteria for Panic Disorder
Exclusion Criteria
* Had received cognitive-behavior therapy for Panic Disorder in the last six months
* Cognitive impairment preventing the completion of psychological assessment
* Past or present psychotic episode, Bipolar Disorder, or organic mental disorder
* Current Abuse or Dependence Disorder
* If another Mental Disorder is present, its severity was equal or inferior to the severity of Panic Disorder
* Current medical condition preventing the participant from receiving pharmacological of cognitive-behavior treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Université du Québec a Montréal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UQAM
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
André Marchand, PhD
Role: PRINCIPAL_INVESTIGATOR
Université du Québec a Montréal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôtel-Dieu de Lévis
Lévis, Quebec, Canada
Institut de Cardiologie de Montréal (Montreal Heart Institute)
Montreal, Quebec, Canada
Hôpital du Sacré-Coeur de Montréal
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Julien Poitras, MD
Role: primary
Alain Vadeboncoeur, MD
Role: primary
Jean-Marc Chauny, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Foldes-Busque G, Hamel S, Belleville G, Fleet R, Poitras J, Chauny JM, Vadeboncoeur A, Lavoie KL, Marchand A. Factors associated with pain level in non-cardiac chest pain patients with comorbid panic disorder. Biopsychosoc Med. 2016 Oct 18;10:30. doi: 10.1186/s13030-016-0081-5. eCollection 2016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MOP 81128 (CIHR)
Identifier Type: -
Identifier Source: org_study_id